Ronald Hunt - Insider Trading & Ownership

Entity
Individual
Location
C/O Credit Suisse 1 St Boston Prv Eqy, 11 Madison Avenue, New York, NY
Summary
The estimated net worth of Ronald Hunt is at least $512K dollars as of August 12, 2024. Ronald Hunt is the Director of Iterum Therapeutics plc and owns shares of Iterum Therapeutics plc (ITRM) stock worth about $483K. Ronald Hunt is the Director of Rallybio Corp and owns shares of Rallybio Corp (RLYB) stock worth about $29.2K.
All Insider Reports
All Insider Reports

Ownership of Ronald Hunt

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ITRM Iterum Therapeutics plc Director $483K Aug 6, 2024
RLYB Rallybio Corp Director $29.2K May 15, 2024
HARP Harpoon Therapeutics, Inc. Director, 10%+ Owner Mar 8, 2024

Insider Transactions Reported by Ronald Hunt:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.